What is AME's Value Score?

AMETEK, Inc. (AME) has a StockPik Value Score of 49 out of 100 — a mid-range score, indicating moderate value characteristics. The Value Score is a composite ranking built from P/E ratio, P/B ratio, Graham Number, ROE, gross margin, debt-to-equity, current ratio, and Piotroski F-Score, calculated from SEC EDGAR annual filing data.

What is AME's Piotroski F-Score?

AMETEK, Inc. (AME) has a Piotroski F-Score of 5 out of 9 — a moderate score. The F-Score assesses nine binary financial criteria across profitability, leverage, and operating efficiency. A score of 7–9 indicates a financially improving company; a score of 0–3 is a warning sign.

Is AME trading below its Graham Number?

AME is currently trading above its Graham Number. The stock price of $227.9 exceeds the Graham Number of $83.22, meaning it does not meet Graham's criterion for a margin of safety at the current price. The Graham Number is calculated as √(22.5 × EPS × Book Value Per Share) and represents Benjamin Graham's ceiling price for a defensive investor.

What is AME's Graham Number?

AME's Graham Number is $83.22, calculated using the Benjamin Graham formula √(22.5 × EPS × Book Value per Share). The Graham Number is an estimate of intrinsic value — the maximum price a defensive investor should pay. At the current price of $227.90, AME is trading 174% above its Graham Number.

What is AME's Piotroski F-Score?

AME's Piotroski F-Score is 5 out of 9, indicating moderate financial health. The Piotroski F-Score evaluates nine criteria across profitability, leverage, and operating efficiency. Scores of 7 or above are considered strong; 3 or below indicate financial weakness.

Is AME (AMETEK, Inc.) undervalued?

AME scores 49/100 on StockPik's Value Score. The stock trades 174% above its Graham Number of $83.22.

What is AME's P/E ratio?

AME's trailing P/E ratio is 35.3x — an elevated earnings multiple, potentially pricing in high growth expectations. The Healthcare sector average P/E is 25.2x. Compare against other Healthcare stocks in the StockPik screener.

Does AMETEK, Inc. (AME) pay a dividend?

Yes, AME currently pays a dividend yield of 0.6%. View the full dividend and value analysis on StockPik.

What sector is AMETEK, Inc. (AME) in?

AMETEK, Inc. (AME) is in the Healthcare sector, specifically in the Industrial Instruments For Measurement, Display, and Control industry. Compare it against other Healthcare stocks by Value Score, P/E ratio, and Piotroski F-Score on StockPik.

Back to Screener

AMETEK, Inc. (AME)

NYSE Large Cap

Healthcare › Industrial Instruments For Measurement, Display, and Control

$227.90

Market Cap: $52.2B

Data as of Mar 31, 2026 (TTM)

Price History

Feb 9, 2026 — May 18, 2026

Investment Snapshot

Trading 174% above Graham Number — above intrinsic value estimate
Piotroski F-Score 5/9 — moderate financial health
ROE of 13.6% — below-average profitability
Revenue growing at 7% annually

AMETEK, Inc. (AME) is a Healthcare company operating in Industrial Instruments For Measurement, Display, and Control, listed on the NYSE , with a market capitalisation of $52.2 billion . Key value metrics: P/E ratio 35.3, P/B ratio 4.78, Piotroski F-Score 5 out of 9 (moderate financial health) .

Value Score

out of 100

Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio

35.27

P/B Ratio

4.78

EPS

$6.46

Div. Yield

0.6%

PEG Ratio

—

P/S Ratio

—

EV/EBITDA

—

ROE

—

ROA

—

Gross Margin

—

Op. Margin

—

Net Margin

—

Debt/Equity

—

Current Ratio

—

Unlock 19 More Metrics — 7 Days Free

Current vs 5-Year Average

Based on 5 years of SEC filings

Net Margin

—

↑ +2.1pp avg —

Gross Margin

—

↑ +2.1pp avg —

Operating Margin

—

↑ +2.1pp avg —

Return on Equity

—

↑ +2.1pp avg —

Debt / Equity

—

↑ +2.1pp avg —

See How Margins & ROE Have Trended — Try PRO

Revenue & Net Income

Profit Margins

Track Gross, Operating & Net Margins — Try PRO

EPS & Free Cash Flow Per Share

See EPS & Free Cash Flow Trends — Try PRO

Financial Statements

Metric	FY22	FY23	FY24
Revenue	$X.XB	$X.XB	$X.XB
Gross Profit	$X.XB	$X.XB	$X.XB
Operating Income	$X.XB	$X.XB	$X.XB
Net Income	$X.XB	$X.XB	$X.XB
EBITDA	$X.XB	$X.XB	$X.XB
Total Assets	$X.XB	$X.XB	$X.XB
Total Liabilities	$X.XB	$X.XB	$X.XB

Unlock 5 Years of Financials — Start Free Trial

Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

AMETEK, Inc. — Fundamental Analysis Summary

AMETEK, Inc. (AME) is currently trading 174% above its Graham Number of $83.22, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 35.3x.

On financial health, AME shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 13.6% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.20.

StockPik's composite Value Score for AME is 49/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

AME reports a moderate gross margin of 36.3% (sector average: 40.1%) and a strong operating margin of 26.2%.

AME shows revenue growing at 7% year-over-year, with earnings growing at 8%.

AME pays a modest dividend yield of 0.6%.

Top Value Stocks in Healthcare

Symbol	Name	Price	P/E	Score
EMBC	Embecta Corp. - Common Stock	$3.90	2.1	100
HCM	HUTCHMED (China) Limited - American Depositary Shares	$13.31	5.1	100
GMAB	Genmab A/S - American Depositary Shares	$27.06	1.8	100
CGEN	Compugen Ltd. - Ordinary Shares	$2.71	7.3	100
INVA	Innoviva, Inc. - Common Stock	$22.89	5.8	100

Browse all Healthcare value stocks →

How is the Value Score calculated?

Read our full methodology →

How is the Graham Number calculated?

Benjamin Graham's intrinsic value formula, worked examples, and how to use it →

AMD — Advanced Micro Devices, Inc. - Common Stock

Affiliated Managers Group, Inc. Common Stock — AMG